Expired Manager Statistical Programming jobs in Palo Alto, CA
Jazz Pharmaceuticals -US
Palo Alto, CA
$60,503-$220,663/year (est.)
Overview: Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We are continuing to expand our commercial product portfolio and our research and...
Palo Alto, CA
$133K-$162K / yr. (est.)
The Senior Manager, Statistical Programmer will be expected to provide timely support to the study team on all programming matters according to project strategies. This role is focused on supporting team. The incumbent should have hands-on skills and experiences in implementing and executing the...
Jazz Pharmaceuticals -US
Palo Alto, CA
$116,391-$217,163/year (est.)
Overview: Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We are continuing to expand our commercial product portfolio and our research and...
Palo Alto, CA
$60,503-$220,663/year (est.)
Overview Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patientsa lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We are continuing to expand our commercial product portfolio and our research and...
Palo Alto, CA
$116,391-$217,163/year (est.)
Accountable for the development and maintenance of the SAS Server setting Responsible for development and validation of CDISC automation tools Lead development of software systems to generate displays of clinical study data Develop software validation procedures and test plans, as necessary. Create...
Palo Alto, CA
$60,503-$220,663/year (est.)
Overview: Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to developing life-changing medicines for people with serious diseases - often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage...